Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, H 302, 94305, Stanford, CA, USA.
Department of Pathology, Stanford University School of Medicine, Stanford, USA.
J Robot Surg. 2020 Feb;14(1):35-40. doi: 10.1007/s11701-019-00928-z. Epub 2019 Jan 28.
Sentinel lymph nodes sampling (SLN) in endometrial cancer is being evaluated as a means to gather prognostic information about lymphatic metastasis while avoiding the morbidity associated with complete lymphadenectomy. SLN ultrastaging has been advocated to identify low-volume metastases, but its value remains uncertain. This study aims to evaluate a pathological protocol for the immediate intraoperative SLN work-up using H&E staining alone. In this retrospective single-center study, patients received standardized cervical injection of indocyanine green, SLN mapping followed by pelvic lymphadenectomy with or without para-aortic lymphadenectomy. SLNs were entirely frozen, multiple H&E stained sections prepared and evaluated intraoperatively. No immunohistochemistry was performed. SLN results were compared with the complete lymphadenectomy specimen. Over 3.5 years, 90 patients were identified who underwent SLN mapping and subsequent complete pelvic lymphadenectomy. At least one SLN was detected in 79 (88%) patients. The median number of SLNs removed was 2.0. Para-aortic SLNs were detected in 7%. Final pathology showed 67% Type I tumors, 76% locally confined. The mean number of lymph nodes removed during complete lymphadenectomy was 21. In this series, only 6 patients had lymph node metastases. 5/6 were identified by the described SLN approach resulting in 83.3% sensitivity and a negative predictive value of 98.7%. Our approach permits immediate intraoperative results and helps guide the primary surgery. The immediate SLN work-up using frozen sections showed both high accuracy and negative predictive value. The comparably lower sensitivity may be related to the low number of patients with positive lymph nodes (7.6%).
前哨淋巴结取样 (SLN) 在子宫内膜癌中被评估为一种获取关于淋巴转移的预后信息的方法,同时避免完全淋巴结清扫术相关的发病率。SLN 超分期已被提倡用于识别低容量转移,但其价值仍不确定。本研究旨在评估一种使用 H&E 染色单独进行即时术中 SLN 工作的病理方案。在这项回顾性单中心研究中,患者接受了标准化的宫颈吲哚菁绿注射、SLN 绘图,随后进行了盆腔淋巴结清扫术,伴或不伴腹主动脉旁淋巴结清扫术。SLN 完全冷冻,准备并在术中进行了多个 H&E 染色切片评估。未进行免疫组织化学检查。将 SLN 结果与完整的淋巴结切除术标本进行比较。在 3.5 年期间,共确定了 90 例接受 SLN 绘图和随后的完整盆腔淋巴结清扫术的患者。79 例(88%)患者至少检测到一个 SLN。切除的 SLN 中位数为 2.0 个。7%的患者检测到腹主动脉旁 SLN。最终病理显示 67%为 I 型肿瘤,76%为局部局限。在完整淋巴结清扫术中切除的淋巴结平均数量为 21 个。在本系列中,只有 6 例患者有淋巴结转移。通过描述的 SLN 方法识别出 5/6 例,敏感性为 83.3%,阴性预测值为 98.7%。我们的方法允许即时进行术中结果,并有助于指导主要手术。使用冷冻切片进行即时 SLN 工作显示出高准确性和阴性预测值。相对较低的敏感性可能与阳性淋巴结患者的数量较少(7.6%)有关。